Home › Cancer (all types) › NCT05415007
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Recruiting
Brief Intervention to Reduce Anxiety and Promote Resilience in Caregivers of Youth With Cancer
Who can join
Ages 8 to 18 · All sexes
Full eligibility criteria
Inclusion and Exclusion Criteria: Parents Inclusion * Child (0-17yrs) with recent (\<12 mo) cancer diagnosis * Fluent in English * Consent to research Exclusion: * Lack of proficiency in written and spoken English * Parent is under age 18 * Active Suicidal Ideation * Child with cancer does not provide assent Inclusion and Exclusion Criteria: Children Inclusion: * Recent (\<12 mo) cancer diagnosis in child * 8-17 Years old * Provides assent to participate in the study Exclusion: * Cannot read English * Parent is not enrolled in the study Anyone who is not a caregiver of children who have been diagnosed with cancer within the past 12 months will be excluded.
About the study
The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.
What is being tested
- GOLD Program (behavioral)
- Treatment as usual (TAU) (behavioral)
Sponsor: Stanford University · Participants: 40 · Started: Sep 21, 2022
Contact the study team
- Victoria E. Cosgrove, PhD · Phone: 650-995-6848
Official record on ClinicalTrials.gov — NCT05415007
Locations in the U.S.
| California | Stanford Cancer Institute, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.